Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review
K Marchand, S Beaumont, J Westfall… - … , prevention, and policy, 2019 - Springer
Background Despite ongoing efforts aimed to improve treatment engagement for people
with substance-related disorders, evidence shows modest rates of utilization as well as …
with substance-related disorders, evidence shows modest rates of utilization as well as …
Association between opioid agonist therapy and testing, treatment uptake, and treatment outcomes for hepatitis C infection among people who inject drugs: a …
Background People who inject drugs (PWID) experience barriers to accessing testing and
treatment for hepatitis C virus (HCV) infection. Opioid agonist therapy (OAT) may provide an …
treatment for hepatitis C virus (HCV) infection. Opioid agonist therapy (OAT) may provide an …
Building healthcare provider relationships for patient-centered care: A qualitative study of the experiences of people receiving injectable opioid agonist treatment
K Marchand, J Foreman, S MacDonald… - … , prevention, and policy, 2020 - Springer
Background Injectable opioid agonist treatment (iOAT) was designed as a pragmatic and
compassionate approach for people who have not benefitted from medication assisted …
compassionate approach for people who have not benefitted from medication assisted …
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Globally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV)
infection, including an estimated 7.5 million people who have recently injected drugs …
infection, including an estimated 7.5 million people who have recently injected drugs …
Telling different stories, making new realities: The ontological politics of 'addiction'biographies
K Pienaar, E Dilkes-Frayne - International Journal of Drug Policy, 2017 - Elsevier
Personal narratives of alcohol and other drug addiction circulate widely in popular culture
and they also have currency in professional therapeutic settings. Despite this, relatively little …
and they also have currency in professional therapeutic settings. Despite this, relatively little …
Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The …
Aim Peer support services have been shown to be beneficial in increasing uptake and
adherence to treatment in other areas but few examples of these services exist in hepatitis C …
adherence to treatment in other areas but few examples of these services exist in hepatitis C …
Should I stay or should I Go? A qualitative exploration of stigma and other factors influencing opioid agonist treatment journeys
VR Carlisle, OM Maynard, D Bagnall… - International Journal of …, 2023 - mdpi.com
Highlights OAT treatment journeys in our sample were influenced by a broad range of
individual, social and structural factors, with stigma presenting a pervasive barrier to …
individual, social and structural factors, with stigma presenting a pervasive barrier to …
Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe)–a natural experiment (protocol)
Introduction Hepatitis C virus (HCV) is the second largest contributor to liver disease in the
UK, with injecting drug use as the main risk factor among the estimated 200 000 people …
UK, with injecting drug use as the main risk factor among the estimated 200 000 people …
“Hepatitis C treatment turned me around:” Psychological and behavioral transformation related to hepatitis C treatment
AW Batchelder, D Peyser, S Nahvi, JH Arnsten… - Drug and Alcohol …, 2015 - Elsevier
Abstract Background Hepatitis C (HCV) is a significant public health problem that primarily
affects current and former substance users. However, individuals with a history of substance …
affects current and former substance users. However, individuals with a history of substance …
Caring and curing: Considering the effects of hepatitis C pharmaceuticalisation in relation to non-clinical treatment outcomes
Background The development of simplified and effective hepatitis C (HCV) pharmaceuticals
enables treatment scale up among the most marginalised. This potentiates a promise of viral …
enables treatment scale up among the most marginalised. This potentiates a promise of viral …